China expects to profit on generic monoclonal antibodies

Among the $ 160 billion value of drug patents which expire in 2015, antiboides will constitute a significant part. Global monoclonal antibody drug market will reach $ 62.8 billion by 2015, and some of the patents will also expire. Chinese companies such as CITIC Healthcare and Watson Biological Co. are expected to profit most.

China Bio news release, December 24, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny